What's new
By:
Filters
Cystic Fibrosis Forum (EXP)

This is a sample guest message. Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!

Vertex trial

P

petersymons

Guest
Just wondering if anyone here is involved in the combined VX770/809 trials?
regards Peter
 
P

petersymons

Guest
Just wondering if anyone here is involved in the combined VX770/809 trials?
regards Peter
 
P

petersymons

Guest
Just wondering if anyone here is involved in the combined VX770/809 trials?
<br />regards Peter
 
L

LiveStrong

New member
Hey Peter,

not sure about the 770/809 trials but seems like vertex will be filing for VX-770 approval this year.

"We are in a unique position, as just behind telaprevir is VX-770, a medicine in development that aims to treat the underlying cause of cystic fibrosis. We will soon obtain data from the Phase 3 registration program of VX-770 that may support the planned submission of a New Drug Application to the FDA in the second half of this year."

<a target=_blank class=ftalternatingbarlinklarge href="http://finance.yahoo.com/news/Vertex-Announces-Key-Business-bw-4211373110.html?x=0&.v=1">http://finance.yahoo.com/news/...11373110.html?x=0&.v=1</a>
 
L

LiveStrong

New member
Hey Peter,

not sure about the 770/809 trials but seems like vertex will be filing for VX-770 approval this year.

"We are in a unique position, as just behind telaprevir is VX-770, a medicine in development that aims to treat the underlying cause of cystic fibrosis. We will soon obtain data from the Phase 3 registration program of VX-770 that may support the planned submission of a New Drug Application to the FDA in the second half of this year."

<a target=_blank class=ftalternatingbarlinklarge href="http://finance.yahoo.com/news/Vertex-Announces-Key-Business-bw-4211373110.html?x=0&.v=1">http://finance.yahoo.com/news/...11373110.html?x=0&.v=1</a>
 
L

LiveStrong

New member
Hey Peter,
<br />
<br />not sure about the 770/809 trials but seems like vertex will be filing for VX-770 approval this year.
<br />
<br />"We are in a unique position, as just behind telaprevir is VX-770, a medicine in development that aims to treat the underlying cause of cystic fibrosis. We will soon obtain data from the Phase 3 registration program of VX-770 that may support the planned submission of a New Drug Application to the FDA in the second half of this year."
<br />
<br /><a target=_blank class=ftalternatingbarlinklarge href="http://finance.yahoo.com/news/Vertex-Announces-Key-Business-bw-4211373110.html?x=0&.v=1">http://finance.yahoo.com/news/...11373110.html?x=0&.v=1</a>
 
You must log in or register to reply here.
Top